Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
JACC. Heart Failure
|
February 5, 2025
Ventricular Reconstruction: A Sledgehammer for a Hammer's Work?
Frederick G P Welt, James C Fang
Circulation
|
March 15, 2006
Cell therapy for acute myocardial infarction: curb your enthusiasm?
Frederick G P Welt, Douglas W Losordo
Circulation
|
April 21, 2025
Evolution of TAVR as a Technology: Do Real-World Outcomes Still Support Expanded Use?
Frederick G P Welt, Jason P Glotzbach
Current Opinion in Cardiology
|
May 1, 2018
Antithrombotic drugs in cardiovascular medicine: a year in review
Homam Ibrahim, Matthew Rondina, Frederick G P Welt
The Journal of Invasive Cardiology
|
January 4, 2017
Bioprosthetic Aortic Paravalvular Leak: Is Valve-in-Valve Another Solution?
Anwar Tandar, David A Bull, Frederick G P Welt
International Journal of Cardiology
|
March 27, 2017
Reply: Anthithrombotic therapy and vascular access site: A choice not mutually exclusive
Tilak K R Pasala, Shari Bolen, Frederick G P Welt
Texas Heart Institute Journal
|
December 21, 2017
Managing Stenotic Septal Perforator Branches
Abdulfattah Saidi, Anwar Tandar, Frederick G P Welt, et al.
Circulation
|
July 14, 2012
The transcatheter valve revolution: time for a compensatory pause
Frederick G P Welt, Michael J Davidson, Andrew C Eisenhauer
JACC. Cardiovascular Interventions
|
March 24, 2017
Acute Coronary Syndrome Resulting From Systolic Compression of Left Main Coronary Artery Secondary to Aortic Subvalvular Aneurysm
Partha Sardar, Evbu Enakpene, James C Fang, et al.
Circulation Research
|
March 9, 2002
Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted
Christopher Horvath, Frederick G P Welt, Mark Nedelman, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
JACC. Heart Failure
|
February 5, 2025
Ventricular Reconstruction: A Sledgehammer for a Hammer's Work?
Frederick G P Welt, James C Fang
Circulation
|
March 15, 2006
Cell therapy for acute myocardial infarction: curb your enthusiasm?
Frederick G P Welt, Douglas W Losordo
Circulation
|
April 21, 2025
Evolution of TAVR as a Technology: Do Real-World Outcomes Still Support Expanded Use?
Frederick G P Welt, Jason P Glotzbach
Current Opinion in Cardiology
|
May 1, 2018
Antithrombotic drugs in cardiovascular medicine: a year in review
Homam Ibrahim, Matthew Rondina, Frederick G P Welt
The Journal of Invasive Cardiology
|
January 4, 2017
Bioprosthetic Aortic Paravalvular Leak: Is Valve-in-Valve Another Solution?
Anwar Tandar, David A Bull, Frederick G P Welt
International Journal of Cardiology
|
March 27, 2017
Reply: Anthithrombotic therapy and vascular access site: A choice not mutually exclusive
Tilak K R Pasala, Shari Bolen, Frederick G P Welt
Texas Heart Institute Journal
|
December 21, 2017
Managing Stenotic Septal Perforator Branches
Abdulfattah Saidi, Anwar Tandar, Frederick G P Welt, et al.
Circulation
|
July 14, 2012
The transcatheter valve revolution: time for a compensatory pause
Frederick G P Welt, Michael J Davidson, Andrew C Eisenhauer
JACC. Cardiovascular Interventions
|
March 24, 2017
Acute Coronary Syndrome Resulting From Systolic Compression of Left Main Coronary Artery Secondary to Aortic Subvalvular Aneurysm
Partha Sardar, Evbu Enakpene, James C Fang, et al.
Circulation Research
|
March 9, 2002
Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted
Christopher Horvath, Frederick G P Welt, Mark Nedelman, et al.
Page
of 6